Last 7 days
-1.8%
Last 30 days
-3.9%
Last 90 days
-8.0%
Trailing 12 Months
-5.4%
Datesorted ascending | Name | Buy/Sell | $ Value | Avg. Price | # Shares | Title |
---|---|---|---|---|---|---|
2023-08-23 | Smith Gregory L | sold | -838,400 | 83.84 | -10,000 | evp global ops & supply chain |
2023-08-14 | Wall Brett A. | sold | -83,380 | 83.38 | -1,000 | evp & pres neuroscience |
2023-08-04 | Marinaro Michael | sold | -113,717 | 84.11 | -1,352 | evp & president, surgical ou |
2023-08-03 | Salmon Sean | acquired | - | - | 5,604 | evp & president cardiovascular |
2023-08-03 | Marinaro Michael | acquired | - | - | 1,696 | evp & president, surgical ou |
2023-08-03 | Marinaro Michael | sold (taxes) | -111,780 | 84.49 | -1,323 | evp & president, surgical ou |
2023-08-03 | TEN HOEDT ROB | acquired | - | - | 4,251 | evp and pres. global regions |
2023-08-03 | WHITE ROBERT JOHN | sold (taxes) | -343,452 | 84.49 | -4,065 | evp & pres. medical surgical |
2023-08-03 | Wall Brett A. | acquired | - | - | 5,168 | evp & pres neuroscience |
2023-08-03 | PARKHILL KAREN L | acquired | - | - | 7,105 | evp & chief financial officer |
Datesorted ascending | Fund Name | Type | % Chg | $ Change | $ Held | % Portfolio |
---|---|---|---|---|---|---|
2023-09-18 | WASHINGTON CAPITAL MANAGEMENT, INC | added | 0.96 | 86,341 | 921,967 | 0.78% |
2023-09-14 | Proquility Private Wealth Partners, LLC | added | 0.18 | 315,910 | 3,648,440 | 1.43% |
2023-09-13 | CGC Financial Services, LLC | new | - | 41,759 | 41,759 | 0.03% |
2023-09-12 | DCM Advisors, LLC | unchanged | - | 74,964 | 882,938 | 0.38% |
2023-09-12 | Farther Finance Advisors, LLC | added | 35.86 | 116,457 | 356,765 | 0.08% |
2023-09-08 | TUCKER ASSET MANAGEMENT LLC | reduced | -3.74 | 1,678 | 34,007 | 0.01% |
2023-09-07 | ST GERMAIN D J CO INC | new | - | 2,710,570 | 2,710,570 | 0.14% |
2023-09-05 | Covenant Partners, LLC | added | 30.58 | 117,402 | 392,397 | 0.14% |
2023-09-05 | Westshore Wealth, LLC | reduced | -2.5 | 14,332 | 233,377 | 0.12% |
2023-09-05 | Delos Wealth Advisors, LLC | unchanged | - | 2,321 | 27,336 | 0.04% |
Date Filed | Name of Filer | Percent of Class | No. of Shares | Form Type | |
---|---|---|---|---|---|
Feb 15, 2023 | blackrock inc. | 9.2% | 122,349,678 | SC 13G/A | |
Feb 09, 2023 | vanguard group inc | 9.41% | 125,126,702 | SC 13G/A | |
Feb 01, 2022 | blackrock inc. | 8.0% | 107,903,361 | SC 13G/A | |
Feb 10, 2021 | vanguard group inc | 8.27% | 111,286,018 | SC 13G/A | |
Feb 03, 2021 | wellington management group llp | 2.87% | 38,648,749 | SC 13G/A | |
Jan 29, 2021 | blackrock inc. | 7.96% | 107,107,760 | SC 13G/A | |
Feb 12, 2020 | vanguard group inc | 8.55% | 114,617,479 | SC 13G/A | |
Feb 05, 2020 | blackrock inc. | 8.2% | 109,561,921 | SC 13G/A | |
Jan 27, 2020 | wellington management group llp | 5.13% | 68,769,139 | SC 13G/A |
Date Filed | Form Type | Document | |
---|---|---|---|
Sep 13, 2023 | ARS | ARS | |
Aug 31, 2023 | 10-Q | Quarterly Report | |
Aug 31, 2023 | IRANNOTICE | IRANNOTICE | |
Aug 25, 2023 | 4 | Insider Trading | |
Aug 23, 2023 | 144 | Notice of Insider Sale Intent | |
Aug 22, 2023 | 8-K | Current Report | |
Aug 16, 2023 | 4 | Insider Trading | |
Aug 14, 2023 | 144 | Notice of Insider Sale Intent | |
Aug 11, 2023 | DEFA14A | DEFA14A | |
Aug 11, 2023 | DEF 14A | DEF 14A |
Name | Mkt Capsorted ascending | Revenue | Price %, 1M | Returns, 1Y | P/E | P/S | Rev 1-Yr | Inc 1-Yr |
---|---|---|---|---|---|---|---|---|
LARGE-CAP | ||||||||
MDT | 107.1B | 31.6B | -3.89% | -5.40% | 29.52 | 3.39 | 1.57% | -30.40% |
ISRG | 99.9B | 6.7B | -0.98% | 45.79% | 70.1 | 14.99 | 11.75% | -0.66% |
EW | 42.7B | 5.7B | -7.62% | -17.65% | 30.7 | 7.54 | 5.64% | -4.53% |
ALGN | 23.0B | 3.7B | -14.60% | 32.47% | 73.17 | 6.15 | -6.33% | -49.26% |
HOLX | 17.3B | 4.0B | -8.83% | 11.42% | 35.74 | 4.28 | -22.73% | -67.98% |
MID-CAP | ||||||||
PEN | 9.6B | 937.8M | -0.82% | 34.59% | 329.38 | 10.23 | 16.30% | 250.21% |
NVST | 4.5B | 2.6B | -15.10% | -17.76% | 20.82 | 1.75 | 1.78% | -15.77% |
CNMD | 3.1B | 1.1B | -4.32% | 17.29% | 35.22 | 2.73 | 9.28% | 177.49% |
LIVN | 3.0B | 1.1B | 0.89% | 9.63% | -30.91 | 2.77 | 6.60% | -233.50% |
TMDX | 1.9B | 151.1M | -13.07% | 24.15% | -104.73 | 12.31 | 193.70% | 62.80% |
SMALL-CAP | ||||||||
ESTA | 1.2B | 177.1M | -13.07% | -17.06% | -20.42 | 7.02 | 23.02% | 15.37% |
AVNS | 941.3M | 780.7M | -8.43% | -11.84% | -26.15 | 1.21 | 4.68% | -510.17% |
BLFS | 550.8M | 162.2M | 12.61% | -45.53% | -6.55 | 3.4 | 9.71% | 12.37% |
INGN | 119.4M | 349.3M | -18.77% | -79.39% | -1.24 | 0.34 | -1.13% | -239.54% |
SDC | 53.9M | 414.9M | -23.07% | -60.47% | -0.65 | 0.13 | -23.37% | 16.91% |
6.1%
0.7%
-2.1%
-7.0%
53.9%
32.7%
0%
Y-axis is the maximum loss one would have experienced if Medtronic was unfortunately bought at previous high price.
Income Statement (Last 12 Months) | (In Millions) | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Description | (%) Q/Q | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 | 2018Q4 | 2018Q3 |
Revenue | 1.1% | 31,559 | 31,227 | 30,772 | 30,808 | 31,070 | 31,686 | 31,785 | 31,797 | 31,597 | 30,117 | 27,927 | 27,869 | 27,928 | 28,914 | 31,062 | 30,891 | 30,666 | 30,557 | 30,555 | 30,378 | 29,947 |
S&GA Expenses | 0.4% | 10,461 | 10,415 | 10,368 | 10,314 | 10,312 | 10,292 | 10,318 | 10,294 | 10,279 | 10,148 | 9,913 | 9,963 | 9,983 | 10,109 | 10,370 | 10,379 | 10,364 | 10,418 | 10,394 | 10,321 | 10,255 |
EBITDA | -100.0% | - | 8,697 | 8,714 | 8,891 | 9,012 | 8,777 | 8,736 | 8,379 | 7,740 | 7,522 | 6,170 | 6,527 | 6,991 | 7,810 | 9,448 | - | - | - | - | - | - |
EBITDA Margin | -100.0% | - | 0.28* | 0.28* | 0.29* | 0.29* | 0.28* | 0.27* | 0.26* | 0.24* | 0.25* | 0.22* | 0.23* | 0.25* | 0.27* | 0.30* | - | - | - | - | - | - |
Interest Expenses | -2.5% | 620 | 636 | 592 | 562 | 580 | 553 | 552 | 558 | 892 | 925 | 946 | 959 | 654 | 1,092 | 1,648 | 1,735 | 1,811 | 1,444 | 1,043 | 1,070 | 1,102 |
Earnings Before Taxes | 2.9% | 5,517 | 5,364 | 5,416 | 5,630 | 5,728 | 5,517 | 5,481 | 5,112 | 4,144 | 3,895 | 2,534 | 2,893 | 3,662 | 4,055 | 5,142 | 4,933 | 4,994 | 5,197 | 5,630 | 5,287 | 5,660 |
EBT Margin | -100.0% | - | 0.17* | 0.18* | 0.18* | 0.18* | 0.17* | 0.17* | 0.16* | 0.13* | 0.13* | 0.09* | 0.10* | 0.13* | 0.14* | 0.17* | - | - | - | - | - | - |
Net Income | -3.5% | 3,627 | 3,758 | 4,071 | 4,329 | 5,211 | 5,039 | 4,926 | 4,716 | 3,893 | 3,606 | 2,901 | 3,546 | 4,423 | 4,809 | 5,335 | 4,689 | 4,433 | 4,631 | 4,919 | 2,261 | 3,163 |
Net Income Margin | -100.0% | - | 0.12* | 0.13* | 0.14* | 0.17* | 0.16* | 0.15* | 0.15* | 0.12* | 0.12* | 0.10* | 0.13* | 0.16* | 0.17* | 0.17* | - | - | - | - | - | - |
Free Cashflow | -100.0% | - | 4,580 | 4,166 | 4,822 | 5,721 | 5,978 | 5,678 | 5,773 | 5,855 | 4,885 | 4,631 | 4,752 | 4,756 | 6,021 | 6,659 | - | - | - | - | - | - |
Balance Sheet | (In Millions) | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Description | (%) Q/Q | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 | 2018Q4 | 2018Q3 |
Assets | -0.2% | 90,776 | 90,948 | 94,134 | 93,241 | 89,914 | 90,981 | 91,804 | 91,756 | 91,802 | 93,083 | 97,270 | 95,886 | 93,906 | 90,689 | 92,822 | 91,053 | 91,268 | 89,694 | 88,730 | 88,150 | 89,721 |
Current Assets | 0.9% | 21,869 | 21,675 | 25,364 | 25,398 | 22,135 | 23,059 | 23,303 | 22,731 | 22,434 | 22,548 | 26,347 | 26,036 | 24,509 | 22,031 | 24,043 | 22,653 | 22,705 | 21,967 | 20,877 | 21,653 | 22,460 |
Cash Equivalents | -13.2% | 1,339 | 1,543 | 4,521 | 4,828 | 2,140 | 3,714 | 3,479 | 2,900 | 3,004 | 3,593 | 5,077 | 6,420 | 6,499 | 4,140 | 3,709 | 3,962 | 5,080 | 4,393 | 3,703 | 3,911 | 4,380 |
Inventory | 7.1% | 5,668 | 5,293 | 5,375 | 5,055 | 4,809 | 4,616 | 4,514 | 4,349 | 4,288 | 4,313 | 4,508 | 4,484 | 4,551 | 4,229 | 4,122 | 4,042 | 3,932 | 3,753 | 3,866 | 3,763 | 3,681 |
Net PPE | 1.7% | 5,665 | 5,569 | 5,437 | 5,298 | 5,281 | 5,413 | 5,251 | 5,188 | 5,162 | 5,221 | 5,023 | 4,938 | 4,882 | 4,828 | 4,764 | 4,756 | 4,711 | 4,675 | 4,593 | 4,536 | 4,524 |
Goodwill | 0.0% | 41,436 | 41,425 | 41,565 | 40,417 | 66.00 | 615 | 80.00 | 80.00 | 41,720 | 41,961 | 805 | 381 | 40,714 | 39,841 | 92.00 | 92.00 | 65.00 | 39,959 | 146 | 60.00 | 62.00 |
Liabilities | 0.3% | 39,410 | 39,283 | 42,516 | 41,184 | 37,071 | 38,260 | 39,091 | 39,596 | 40,137 | 41,481 | 46,342 | 45,570 | 43,463 | 39,817 | 40,869 | 40,334 | 40,771 | 39,482 | 38,789 | 38,436 | 39,392 |
Current Liabilities | 0.0% | 9,047 | 9,051 | 14,422 | 14,465 | 14,049 | 12,394 | 8,927 | 7,803 | 7,764 | 8,509 | 12,534 | 12,071 | 13,086 | 10,366 | 8,735 | 8,170 | 8,518 | 8,472 | 8,853 | 8,463 | 9,112 |
Long Term Debt | 0.5% | 24,463 | 24,344 | 22,210 | 20,753 | 17,481 | 20,372 | 24,290 | 25,607 | 25,958 | 26,378 | 26,502 | 25,967 | 22,867 | 22,021 | 24,732 | 24,752 | 24,804 | 24,486 | 23,674 | 23,673 | 23,678 |
Shareholder's Equity | -0.6% | 51,178 | 51,483 | 51,441 | 52,057 | 52,843 | 52,722 | 52,713 | 52,159 | 51,664 | 51,602 | 50,928 | 50,316 | 50,443 | 50,872 | 51,953 | 50,719 | 50,497 | 50,212 | 49,941 | 49,714 | 50,329 |
Retained Earnings | -0.4% | 30,265 | 30,392 | 30,117 | 29,799 | 30,276 | 30,250 | 29,607 | 28,974 | 28,511 | 28,594 | 28,015 | 27,526 | 27,817 | 28,132 | 28,210 | 27,018 | 26,377 | 26,270 | 25,769 | 25,171 | 24,730 |
Additional Paid-In Capital | 0.0% | 24,587 | 24,590 | 24,513 | 24,442 | 24,335 | 24,566 | 25,814 | 26,059 | 26,184 | 26,319 | 26,665 | 26,481 | 26,261 | 26,165 | 26,144 | 26,171 | 26,470 | 26,532 | 26,518 | 27,048 | 27,817 |
Accumulated Depreciation | - | - | - | 8,489 | 8,199 | 8,043 | 7,952 | 7,823 | 7,790 | 7,646 | 7,479 | 7,375 | 7,260 | 7,070 | 6,816 | 6,743 | 6,608 | 6,425 | 6,245 | 6,153 | 5,976 | 5,812 |
Shares Outstanding | 0.0% | 1,330 | 1,331 | 1,330 | 1,330 | 1,329 | 1,331 | 1,344 | 1,345 | 1,345 | 1,345 | 1,346 | 1,344 | 1,342 | 1,341 | 1,341 | 1,341 | 1,341 | 1,341 | 1,343 | 1,349 | 1,353 |
Minority Interest | 3.3% | 188 | 182 | 177 | 177 | 170 | 171 | 171 | 168 | 178 | 174 | 170 | 152 | 147 | 135 | 145 | 141 | 134 | 121 | 112 | 107 | 105 |
Cashflow (Last 12 Months) | (In Millions) | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Description | (%) Q/Q | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 | 2018Q4 | 2018Q3 |
Cashflow From Operations | -3.4% | 5,831 | 6,039 | 5,636 | 6,290 | 7,137 | 7,346 | 7,034 | 7,162 | 7,254 | 6,240 | 5,945 | 5,996 | 6,002 | 7,234 | 7,871 | 7,519 | 6,815 | 7,007 | 5,958 | 5,905 | 5,649 |
Share Based Compensation | 3.1% | 366 | 355 | 352 | 349 | 352 | 359 | 356 | 343 | 343 | 344 | 337 | 338 | 306 | 297 | 297 | 291 | 287 | 290 | 302 | 314 | 316 |
Cashflow From Investing | 29.9% | -2,447 | -3,493 | -2,747 | -2,897 | -2,460 | -1,659 | -11.00 | -2,347 | -3,658 | -2,866 | -4,420 | -3,448 | -2,644 | -3,203 | -4,097 | -3,305 | -1,968 | -774 | -134 | 497 | 6,418 |
Cashflow From Financing | 9.1% | -4,511 | -4,960 | -2,019 | -1,062 | -5,231 | -5,336 | -8,516 | -8,337 | -7,150 | -4,136 | -317 | -192 | -1,965 | -4,198 | -3,748 | -4,143 | -4,132 | -5,431 | -8,399 | -7,980 | -12,386 |
Dividend Payments | 0.4% | 3,631 | 3,616 | 3,554 | 3,497 | 3,440 | 3,383 | 3,321 | 3,255 | 3,188 | 3,120 | 3,063 | 3,005 | 2,948 | 2,894 | 2,841 | 2,789 | 2,740 | 2,693 | 2,646 | 2,598 | 2,546 |
Buy Backs | -38.4% | 397 | 645 | 1,890 | 2,199 | 2,472 | 2,544 | 1,616 | 1,253 | 963 | 652 | 195 | 422 | 906 | 1,326 | 1,265 | 1,701 | 2,320 | 2,877 | 2,870 | 2,274 | 1,758 |
Consolidated Statements of Income (Unaudited) - USD ($) shares in Millions, $ in Millions | 3 Months Ended | |
---|---|---|
Jul. 28, 2023 | Jul. 29, 2022 | |
Income Statement [Abstract] | ||
Net sales | $ 7,702 | $ 7,371 |
Costs and expenses: | ||
Cost of products sold, excluding amortization of intangible assets | 2,628 | 2,516 |
Research and development expense | 668 | 692 |
Selling, general, and administrative expense | 2,613 | 2,567 |
Amortization of intangible assets | 429 | 423 |
Restructuring charges, net | 54 | 14 |
Certain litigation charges | 40 | 0 |
Other operating expense, net | 1 | 35 |
Operating profit | 1,268 | 1,125 |
Other non-operating income, net | (76) | (83) |
Interest expense, net | 148 | 164 |
Income before income taxes | 1,196 | 1,044 |
Income tax provision | 400 | 112 |
Net income | 797 | 931 |
Net income attributable to noncontrolling interests | (6) | (2) |
Net income attributable to Medtronic | $ 791 | $ 929 |
Basic earnings per share (usd per share) | $ 0.59 | $ 0.70 |
Diluted earnings per share (usd per share) | $ 0.59 | $ 0.70 |
Basic weighted average shares outstanding (shares) | 1,330.5 | 1,329.4 |
Diluted weighted average shares outstanding (shares) | 1,333.8 | 1,334.5 |
Consolidated Balance Sheets (Unaudited) - USD ($) $ in Millions | Jul. 28, 2023 | Apr. 28, 2023 |
---|---|---|
Current assets: | ||
Cash and cash equivalents | $ 1,339 | $ 1,543 |
Investments | 6,537 | 6,416 |
Accounts receivable, less allowances and credit losses of $190 and $176, respectively | 5,806 | 5,998 |
Inventories, net | 5,668 | 5,293 |
Other current assets | 2,518 | 2,425 |
Total current assets | 21,869 | 21,675 |
Property, plant, and equipment, net | 5,665 | 5,569 |
Goodwill | 41,436 | 41,425 |
Other intangible assets, net | 14,434 | 14,844 |
Tax assets | 3,461 | 3,477 |
Other assets | 3,912 | 3,959 |
Total assets | 90,776 | 90,948 |
Current liabilities: | ||
Current debt obligations | 519 | 20 |
Accounts payable | 2,239 | 2,662 |
Accrued compensation | 1,695 | 1,949 |
Accrued income taxes | 1,013 | 840 |
Other accrued expenses | 3,581 | 3,581 |
Total current liabilities | 9,047 | 9,051 |
Long-term debt | 24,463 | 24,344 |
Accrued compensation and retirement benefits | 1,092 | 1,093 |
Accrued income taxes | 2,407 | 2,360 |
Deferred tax liabilities | 687 | 708 |
Other liabilities | 1,715 | 1,727 |
Total liabilities | 39,410 | 39,283 |
Commitments and contingencies (Note 16) | ||
Shareholders’ equity: | ||
Ordinary shares— par value $0.0001, 2.6 billion shares authorized, 1,330,498,304 and 1,330,809,036 shares issued and outstanding, respectively | 0 | 0 |
Additional paid-in capital | 24,587 | 24,590 |
Retained earnings | 30,265 | 30,392 |
Accumulated other comprehensive loss | (3,674) | (3,499) |
Total shareholders’ equity | 51,178 | 51,483 |
Noncontrolling interests | 188 | 182 |
Total equity | 51,366 | 51,665 |
Total liabilities and equity | $ 90,776 | $ 90,948 |